Back
Day Range
$13.76
$14.10
52-Week Range
$9.53
$19.85
Volume
2,691,374
50D / 200D Avg
$16.87
/
$15.41
Prev Close
$13.50
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 50.6 | 0.4 |
| P/B | 6.5 | 2.9 |
| ROE % | 15.4 | 3.8 |
| Net Margin % | 6.7 | 3.9 |
| Rev Growth 5Y % | 5.7 | 10.0 |
| D/E | 3.8 | 0.2 |
Key Takeaways
Revenue grew 5.72% annually over 5 years — modest growth
Earnings grew 75.57% over the past year
ROE of 15.42% — decent returns on equity
Debt/Equity of 3.75 — high leverage
Generating 149.18M in free cash flow
P/E of 50.64 — premium valuation
Growth
Revenue Growth (5Y)
5.72%
Revenue (1Y)5.74%
Earnings (1Y)75.57%
FCF Growth (3Y)N/A
Quality
Return on Equity
15.42%
ROIC10.23%
Net Margin6.70%
Op. Margin33.75%
Safety
Debt / Equity
3.75
Current Ratio2.46
Interest Coverage2.52
Valuation
P/E Ratio
50.64
P/B Ratio6.51
EV/EBITDA14.96
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.74% | Revenue Growth (3Y) | 5.31% |
| Earnings Growth (1Y) | 75.57% | Earnings Growth (3Y) | 23.18% |
| Revenue Growth (5Y) | 5.72% | Earnings Growth (5Y) | -9.63% |
| Profitability | |||
| Revenue (TTM) | 1.16B | Net Income (TTM) | 77.95M |
| ROE | 15.42% | ROA | 2.39% |
| Gross Margin | 55.48% | Operating Margin | 33.75% |
| Net Margin | 6.70% | Free Cash Flow (TTM) | 149.18M |
| ROIC | 10.23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3.75 | Current Ratio | 2.46 |
| Interest Coverage | 2.52 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 50.64 | P/B Ratio | 6.51 |
| P/S Ratio | 3.39 | PEG Ratio | 0.93 |
| EV/EBITDA | 14.96 | Dividend Yield | 0.00% |
| Market Cap | 3.95B | Enterprise Value | 5.87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.16B | 1.10B | 1.05B | 1.00B | 931.48M |
| Net Income | 77.95M | 44.40M | 51.38M | -233.57M | 116.88M |
| EPS (Diluted) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 |
| Gross Profit | 645.53M | 602.30M | 577.16M | 557.00M | 518.67M |
| Operating Income | 392.77M | 297.63M | 276.69M | 248.35M | 256.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.26B | 3.07B | 3.13B | 3.12B | 2.79B |
| Total Liabilities | 2.66B | 2.67B | 2.69B | 2.77B | 2.20B |
| Shareholders' Equity | 606.04M | 404.91M | 443.73M | 350.24M | 586.10M |
| Total Debt | 2.27B | 2.35B | 2.33B | 2.03B | 1.83B |
| Cash & Equivalents | 346.46M | 277.24M | 296.41M | 395.21M | 106.92M |
| Current Assets | 613.41M | 526.04M | 557.24M | 645.01M | 345.96M |
| Current Liabilities | 249.58M | 191.00M | 230.65M | 791.57M | 161.16M |